U.S., Feb. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07428681) titled 'Lorazepam for Delirium Prevention in Critically Ill Patients With High Anttila-Index' on Feb. 17.
Brief Summary: Delirium is a neuropsychiatric syndrome characterized by cognitive and attentional deficits, circadian rhythm, emotional and psychomotor dysregulation.
It is frequently encountered in patients admitted to an Intensive Care Unit (ICU) with a prevalence of 20-80% and associated with higher morbidity and mortality, prolonged hospitalization and cognitive impairment after hospitalization.
Alcoholism is an important risk factor that favors the development of delirium and a common comorbidity in patients admitted to the ICU....